Clinical trial
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast…
NCT00381368 · University of Turku, Other · Unknown status
Key facts
| NCT number | NCT00381368 |
|---|---|
| Title | Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients |
| Official title | Phase II Open Label Study to Establish the Safety and Efficacy of Intravenous Loading Dose of Ibandronate 6 mg in 3 Consecutive Days in Breast Cancer Patients With Skeletal Metastases |
| Lead sponsor | University of Turku, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Ibandronic acid |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| First posted | Sep 27, 2006 |
| Last update posted | Dec 4, 2006 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: